Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Horwatitsch

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
International Journal of Clinical Pharmacology, Therapy, and Toxicology|April 1, 1983
Plasma concentration of cutaneously applied trinitroglycerinD Magometschnigg, H Horwatitsch, M Pichler
Deutsche Medizinische Wochenschrift (1946)|June 15, 1979
[Biological availability of spironolactone in two different galenic forms (author's transl)]H Rameis, G Hitzenberger, H Horwatitsch
International Journal of Clinical Pharmacology, Therapy, and Toxicology|July 1, 1982
The bioavailability of spironolactone hydrochlorothiazide combination preparationH Rameis, G Hitzenberger, H Horwatitsch
Steroids and Lipids Research|January 1, 1973
Examinations of the cycle of the pig and cow by means of a common progesterone-series method of analysisE Laube, H Horwatitsch, H Szekely, et al.
Advances in Clinical Pharmacology|January 1, 1978
[Blood level of mexiletine in liver-damaged patients]M Winter, H Brunner, H Horwatitsch, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|December 1, 1985
Pharmacokinetics and bioavailability of isosorbide-5-mononitrate in humansH Rameis, S Bacher, H G Eichler, et al.
Steroidologia|January 1, 1971
[Progesterone in body fluids]E Laube, B Laube, H Horwatitsch, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
International Journal of Clinical Pharmacology, Therapy, and Toxicology|April 1, 1983
Plasma concentration of cutaneously applied trinitroglycerinD Magometschnigg, H Horwatitsch, M Pichler
Deutsche Medizinische Wochenschrift (1946)|June 15, 1979
[Biological availability of spironolactone in two different galenic forms (author's transl)]H Rameis, G Hitzenberger, H Horwatitsch
International Journal of Clinical Pharmacology, Therapy, and Toxicology|July 1, 1982
The bioavailability of spironolactone hydrochlorothiazide combination preparationH Rameis, G Hitzenberger, H Horwatitsch
Steroids and Lipids Research|January 1, 1973
Examinations of the cycle of the pig and cow by means of a common progesterone-series method of analysisE Laube, H Horwatitsch, H Szekely, et al.
Advances in Clinical Pharmacology|January 1, 1978
[Blood level of mexiletine in liver-damaged patients]M Winter, H Brunner, H Horwatitsch, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|December 1, 1985
Pharmacokinetics and bioavailability of isosorbide-5-mononitrate in humansH Rameis, S Bacher, H G Eichler, et al.
Steroidologia|January 1, 1971
[Progesterone in body fluids]E Laube, B Laube, H Horwatitsch, et al.
Pageof 1